EndoGI is a medical device company transforming the traditional non-vascular stenting market, with focus on Endoscopic Gastro-ERCP space. EndoGI innovative, safe and affordable, Single & Multiple stent delivery systems assists in reducing cost, procedure time, steps and associated complications at biliary, pancreatic and urologic stent placement procedures. EndoGI has received two different FDA marketing clearances-510 (k) regulatory approvals on single and multiple stent and delivery system and has launched initial post regulatory approval clinical studies- First in Human.